Ed W. McLean | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Ed W. McLean is active.

Explore More

Publication

Featured researches published by Ed W. McLean.

Journal of The Chemical Society, Chemical Communications | 1994

1,4-Diazabicyclo[2.2.2]octane (DABCO)-catalysed hydrolysis and alcoholysis reactions of 2-amino-9-benzyl-6-chloro-9H-purine

James A. Linn; Ed W. McLean; James L. Kelley

2-Amino-9-benzyl-6-chloro-9H-purine 1 is hydrolysed in refluxing water in the presence of 1,4-diazabicyclo[2.2.2]octane (DABCO) to give 2-amino-9-benzyl-1,6-dihydro-6-oxo-9H-purine 3; however, 1 reacts with hydroxide ion at ambient temp., or analcohol and potassium carbonate at elevated temperatures, in the presence of DABCO togive 3 or 6-alkoxy-2-amino-9-benzyl-9H-purines 4–8, respectively.

Journal of Medicinal Chemistry | 1995

1-(Fluorobenzyl)-4-amino-1H-1,2,3-triazolo[4,5-c]pyridines: synthesis and anticonvulsant activity.

James L. Kelley; Cecilia S. Koble; Ronda Davis; Ed W. McLean; Francis E. Soroko; Barrett R. Cooper

Journal of Medicinal Chemistry | 2005

Application of Phosphoramidate Pronucleotide Technology to Abacavir Leads to a Significant Enhancement of Antiviral Potency

Christopher McGuigan; Sarah Harris; Susan Daluge; Kristjan Gudmundsson; Ed W. McLean; Thimysta C. Burnette; Harry Marr; Richard J. Hazen; Lynn D. Condreay; Lance C. Johnson; Erik De Clercq; Jan Balzarini

Bioorganic & Medicinal Chemistry Letters | 2006

Ultra-potent P1 modified arylsulfonamide HIV protease inhibitors: The discovery of GW0385.

John F. Miller; C. Webster Andrews; Michael Stephen Brieger; Eric S. Furfine; Michael R. Hale; Mary H. Hanlon; Richard J. Hazen; Istvan Kaldor; Ed W. McLean; David J. Reynolds; Douglas Mccord Sammond; Andrew Spaltenstein; Roger D. Tung; Elizabeth M. Turner; Robert X. Xu; Ronald G. Sherrill

Archive | 2003

Piperidine derivatives as ccr5 antagonists

Wieslaw M. Kazmierski; Christopher Joseph Aquino; Neil Bifulco; Eric E. Boros; Brian Andrew Chauder; Pek Yoke Chong; Maosheng Duan; Jr. Felix Deanda; Cecilia S. Koble; Ed W. McLean; Jennifer Poole Peckham; Angilique C Perkins; James B. Thompson; Dana Vanderwall

Journal of Medicinal Chemistry | 2006

Application of Phosphoramidate ProTide Technology Significantly Improves Antiviral Potency of Carbocyclic Adenosine Derivatives

Christopher McGuigan; Alshaimaa Hassan-Abdallah; Sheila Srinivasan; Yikang Wang; Adam Siddiqui; Susan Daluge; Kristjan Gudmundsson; Huiqiang Zhou; Ed W. McLean; Jennifer Poole Peckham; Thimysta C. Burnette; Harry Marr; Richard J. Hazen; Lynn D. Condreay; Lance C. Johnson; Jan Balzarini

Journal of Medicinal Chemistry | 1977

Attempted inhibition of histidine decarboxylase with beta-alkyl analogues of histidine.

James L. Kelley; Carl Miller; Ed W. McLean

Journal of Medicinal Chemistry | 2003

Indanylidenes. 1. Design and synthesis of (E)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity.

David L. Musso; Felicia R. Cochran; James L. Kelley; Ed W. McLean; Jeffrey L. Selph; Greg C. Rigdon; G. Faye Orr; Ronda Davis; Barrett R. Cooper; Virgil L. Styles; James B. Thompson; William R. Hall

Journal of Medicinal Chemistry | 1995